000 04429nam a22004335i 4500
999 _c11033
_d11033
001 11033
003 DE-He213
005 20210629040336.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 180503s2018 gw | s |||| 0|eng d
020 _a9783319543109
024 7 _a10.1007/978-3-319-54310-9
_2doi
040 _aES-MaUEC
_bspa
_dES-VaUE
050 4 _aRD123.5
_b.H37 2018 EB
245 1 0 _aHaploidentical Transplantation:
_bConcepts & Clinical Application
_cedited by Stefan O. Ciurea, Rupert Handgretinger.
264 1 _aCham, Switzerland
_bSpringer
_c2018
300 _a1 recurso en línea (XI, 337 páginas 25 ilustraciones, 18 ilustraciones a color)
336 _2rdacontent
_aTexto (visual)
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aAdvances and Controversies in Hematopoietic Transplantation and Cell Therapy
_x2569-1376
490 0 _aMedicine (Springer-11650)
505 0 _aHistorical perspective and current trends in haploidentical transplantion -- Part 1: Graft manipulation and methods to control T-cell alloreactivity. -Positive CD34+ cell selection -- Selective allo-depletion: αβ and CD19+ cell  T cell depletion -- T cell addback in T- cell depleted haploidentical transplant -- Hematopoietic myeloid growth factor primed bone marrow and peripheral blood hematopoietic progenitor cells -- Photodepletion of allo-reactive T cells -- Post-transplant cyclophosphamide in haploidentical transplant -- Part 2: Ideal graft & donor -- Graft source: Marrow versus peripheral blood with PTCy- Does it matter? -- Anti-HLA antibodies: Assessment and mitigating strategies -- Selection of haploidentical donors: What is the art? -- Myeloablative versus non-myeloablative conditioning regimen- Does it matter and how best to select? -- Part 3: Disease-specific pediatric population -- Nonmalignant diseases in children.-  en.-="" part="" 4:="" disease-specific="" adult="" population.-="" non-malignant="" adults.-="" acute="" myelogenous="" leukemia="" lymphomas-="" parameswaran="" hari.-="" chronic="" leukemias="" and="" myeloproliferative="" neoplasms.-="" immunologic="" reconstitution="" after="" haploidentical="" transplantation.-="" prevention="" treatment="" of="" relapse="" transplant.-="" unique="" complications="" limitations="" future="" prospects="" transplantation.
520 3 _aIn this book, world-renowned experts in the field express well-reasoned opinions on a range of issues and controversies relating to haploidentical transplantation with the aim of providing practicing hematologists with clinically relevant and readily applicable information. Among the areas covered are graft manipulation and methods to control T-cell alloreactivity, the nature of the ideal graft and donor, haploidentical transplantation in pediatric and adult patients with malignant and nonmalignant diseases, immunologic reconstitution following transplantation, complications, and the prevention and treatment of relapse post transplantation. Attention is drawn to the implications of high-impact clinical trials whenever such trials are available. The readily intelligible text is complemented by numerous helpful tables, algorithms, and figures. The book will provide practical support for hematologists and transplant physicians as they attempt to provide optimal care in this exciting but increasingly complex medical specialty.
988 _aEBSPRINGER_2018
650 7 _aCélulas madre hematopoyéticas
_9165039
650 7 _9140122
_aHematología
650 7 _aOncología
_9139207
700 1 _aCiurea, Stefan O.
_eeditor literario
_0http://id.loc.gov/authorities/names/n2018186871
_0http://viaf.org/viaf/19153651664955781380
700 1 _aHandgretinger, Rupert.
_eeditor literario
_0http://id.loc.gov/authorities/names/n2018186872
_0http://viaf.org/viaf/18153651663655781393
710 2 _aSpringerLink (Online service)
_0http://id.loc.gov/authorities/names/no2005046756
_0http://viaf.org/viaf/148105729
_9106996
776 0 8 _iEdición impresa:
_z9783319543093
776 0 8 _iEdición impresa:
_z9783319543116
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-54310-9
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db
_feng
_ggw
_h0